Paper39138705
E-cadherin staining in the diagnosis of lobular versus ductal neoplasms of the breast: the emperor has no clothes.
Taha SR and 1 other. Histopathology, 2025. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. E-cadherin staining in the diagnosis of lobular versus ductal neoplasms of the breast: the emperor has no clothes. Papers, record 39138705. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39138705
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- E-cadherin staining in the diagnosis of lobular versus ductal neoplasms of the breast: the emperor has no clothes.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers, Tumor | Major topic |
| Breast Neoplasms | Major topic |
| Cadherins | Major topic |
| Carcinoma, Ductal, Breast | Major topic |
| Carcinoma, Lobular | Major topic |
| Female | |
| Humans | |
| Immunohistochemistry | |
| Antigens, CD |
Source PubMed
References90
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36482279 | Update on lobular lesions of the breast. | Histopathology | 2023 | https://conductscience.org/library/papers/36482279 | PubMed |
| 2 | 7534041 | Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features. | Am J Pathol | 1995 | https://conductscience.org/library/papers/7534041 | PubMed |
| 3 | 37537585 | Anoikis resistance--protagonists of breast cancer cells survive and metastasize after ECM detachment. | Cell Commun Signal | 2023 | https://conductscience.org/library/papers/37537585 | PubMed |
| 4 | 8197774 | Evaluation and management of high risk and premalignant lesions of the breast. | World J Surg | 1994 | https://conductscience.org/library/papers/8197774 | PubMed |
| 5 | 28190105 | EMT promoting transcription factors as prognostic markers in human breast cancer. | Arch Gynecol Obstet | 2017 | https://conductscience.org/library/papers/28190105 | PubMed |
| 6 | 16230078 | Extracellular cleavage of E-cadherin by leukocyte elastase during acute experimental pancreatitis in rats. | Gastroenterology | 2005 | https://conductscience.org/library/papers/16230078 | PubMed |
| 7 | 17097565 | Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. | Cancer Cell | 2006 | https://conductscience.org/library/papers/17097565 | PubMed |
| 8 | 19789364 | Changes in CpG islands promoter methylation patterns during ductal breast carcinoma progression. | Cancer Epidemiol Biomarkers Prev | 2009 | https://conductscience.org/library/papers/19789364 | PubMed |
| 9 | 19403558 | The role of N-acetylglucosaminyltransferase III and V in the post-transcriptional modifications of E-cadherin. | Hum Mol Genet | 2009 | https://conductscience.org/library/papers/19403558 | PubMed |
| 10 | 27073531 | CDH1 promoter methylation correlates with decreased gene expression and poor prognosis in patients with breast cancer. | Oncol Lett | 2016 | https://conductscience.org/library/papers/27073531 | PubMed |
| 11 | 12800196 | Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability. | Int J Cancer | 2003 | https://conductscience.org/library/papers/12800196 | PubMed |
| 12 | 28764784 | E-cadherin expression phenotypes associated with molecular subtypes in invasive non-lobular breast cancer: evidence from a retrospective study and meta-analysis. | World J Surg Oncol | 2017 | https://conductscience.org/library/papers/28764784 | PubMed |
| 13 | 19294736 | Epigenetic silencing in non-neoplastic epithelia identifies E-cadherin (CDH1) as a target for chemoprevention of lobular neoplasia. | J Pathol | 2009 | https://conductscience.org/library/papers/19294736 | PubMed |
| 14 | 37833450 | The impact of histologic subtype on primary site surgery in the management of metastatic lobular versus ductal breast cancer: a population based study from the National Cancer Database (NCDB). | Breast Cancer Res Treat | 2024 | https://conductscience.org/library/papers/37833450 | PubMed |
| 15 | 35348974 | Multi-omics analyses provide novel biological insights to distinguish lobular ductal types of invasive breast cancers. | Breast Cancer Res Treat | 2022 | https://conductscience.org/library/papers/35348974 | PubMed |
| 16 | 31239068 | Invasive lobular breast cancer: A review of pathogenesis, diagnosis, management, and future directions of early stage disease. | Semin Oncol | 2019 | https://conductscience.org/library/papers/31239068 | PubMed |
| 17 | 31781079 | The E-Cadherin Cleavage Associated to Pathogenic Bacteria Infections Can Favor Bacterial Invasion and Transmigration, Dysregulation of the Immune Response and Cancer Induction in Humans. | Front Microbiol | 2019 | https://conductscience.org/library/papers/31781079 | PubMed |
| 18 | 21104290 | Modulation of E-cadherin function and dysfunction by N-glycosylation. | Cell Mol Life Sci | 2011 | https://conductscience.org/library/papers/21104290 | PubMed |
| 19 | 22659456 | Dishonorable discharge: the oncogenic roles of cleaved E-cadherin fragments. | Cancer Res | 2012 | https://conductscience.org/library/papers/22659456 | PubMed |
| 20 | 36239760 | Clinicopathological Features and Outcomes Comparing Patients With Invasive Ductal and Lobular Breast Cancer. | J Natl Cancer Inst | 2022 | https://conductscience.org/library/papers/36239760 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42352496 | Genomic Profiling of Breast Cancer in an Ecuadorian Cohort Reveals Clinically Relevant Variants and Ancestry-Related Interpretation Challenges. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42352496 | PubMed |
| 41751248 | The Complex Path from Mammary Ductal Hyperplasia to Breast Cancer: Elevated Malignancy Risk in Atypical Forms. | Biomedicines | 2026 | https://conductscience.org/library/papers/41751248 | PubMed |
| 41049266 | Breast Cancer: Molecular Pathogenesis and Targeted Therapy. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/41049266 | PubMed |
| 40911019 | NMD-insensitive CDH1 mutation as a mechanism for retained E-cadherin protein expression in lobular carcinoma in situ (LCIS). | Histopathology | 2025 | https://conductscience.org/library/papers/40911019 | PubMed |
| 39549221 | Comprehensive characterization of invasive mammary carcinoma with lobular features: integrating morphology and E-cadherin immunohistochemistry patterns. | Breast Cancer | 2025 | https://conductscience.org/library/papers/39549221 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CDH1 | 999 | PubTator's text mining | https://conductscience.org/library/genes/999 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39138705
GET https://conductscience.org/api/papers/v1/39138705/references?page=2